Pharmaceutical Development Solutions
Accela Sciences, LLC
Andrew C. Kolbert, Ph.D., M.T.M., President of Accela Sciences, LLC, has fourteen years of experience executing and managing programs from materials sourcing, formulation, and analytical development, through packaging development and manufacturing in the US, Europe, China, and India. His core expertise is analytical and structural chemistry, analysis of API and finished dosage forms, and CMC product development. He was recently the R&D Director of Velcera, a specialty pharmaceutical company where he directed all preclinical product development. At Cardinal Health, Pharmaceutical Technology and Services, he managed a structural and analytical chemistry business unit, which served pharmaceutical clients with a wide range of analytical, problem solving, and CMC development services. Previously at Honeywell, he worked as a Six Sigma green belt in process improvement saving millions of dollars in cost, increased throughput, and improved quality. Dr. Kolbert holds a Ph.D. in Chemical Physics from M.I.T., and a Masters in Technology Management from the Stevens Institute of Technology.